Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Extracellular proteases are enzymes that catalyze the hydrolysis of peptide bonds in the extracellular environment. They are classified based on their catalytic mechanisms into serine proteases, metalloproteinases, cysteine proteases, aspartate proteases, and threonine proteases. These enzymes play crucial roles in various physiological and pathological processes including tissue remodeling, wound healing, inflammation, and cancer progression. Their expression is tightly regulated at multiple levels to ensure precise spatial-temporal control. Dysregulation of extracellular protease activity is implicated in diseases like cancer, cardiovascular diseases, and chronic inflammation, making them important drug targets.
Inhibition of protease activity
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Extracellular Proteases.